Quantcast

Latest Breast cancer Stories

2014-05-05 20:25:53

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Molecular Diagnostics in Cancer Testinghttp://www.reportbuyer.com/pharma_healthcare/diagnostics/molecular_diagnostics_cancer_testing.htmlMolecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA...

2014-05-05 20:23:45

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/treatments/hormone_sensitive_breast_cancer_global_clinical_trials_review_h1_2014.htmlHormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014" provides...

2014-05-05 12:29:18

SCHAUMBURG, Ill., May 5, 2014 /PRNewswire-USNewswire/ -- Edgar Staren, MD, Ph.D., MBA, President and CEO of Cancer Treatment Centers of America® (CTCA) Medicine and Science has been selected to present new research on approaches to the treatment of primary and recurrent breast cancer at the American Society of Breast Surgeons 15(th) Annual Meeting in Las Vegas, NV on Friday, May, 2, 2014. Dr. Staren presented his abstract titled "Initial Experience with Genomic Profiling of...

2014-05-05 10:25:43

A new study reports that sleep efficiency, a ratio of time asleep to time spent in bed, is predictive of survival time for women with advanced breast cancer. Results show that higher sleep efficiency was significantly associated with lower mortality over the ensuing six years, an effect that remained after adjusting for baseline prognostic factors such as age, estrogen receptor status and treatments received. Mean survival was 68.9 months for efficient sleepers compared with 33.2 months...

2014-05-05 10:19:35

Findings and Significance: During breast-tissue development, a transcription factor called SLUG plays a role in regulating stem cell function and determines whether breast cells will mature into luminal or basal cells. Studying factors, such as SLUG, that regulate stem-cell activity and breast-cell identity are important for understanding how breast tumors arise and develop into different subtypes. Ultimately, this knowledge may help the development of novel therapies targeted to specific...

2014-05-05 08:28:31

New Data Include Results on Oncotype DX's Prognosis of Late Recurrence in Invasive Breast Cancer and Clinical Utility in Ductal Carcinoma In Situ (DCIS) REDWOOD CITY, Calif., May 5, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from nine studies of Oncotype DX(®) in breast, colon, prostate and renal cancer will be presented at the American Society of Clinical Oncology(®) (ASCO(®)) Annual Meeting, taking place May 30 - June 3, 2014 at McCormick Place...

2014-05-04 20:21:32

Alliance of Australian and U.S. researchers and children's cancer advocates focused on developing drugs as potential treatments for neuroblastoma, the most common solid form of childhood cancer SYDNEY and COLUMBUS, Ohio, May 4, 2014 /PRNewswire/ -- Researchers and children's cancer advocates in Australia and the U.S. have formed a unique research and development alliance to facilitate development of treatments for children fighting neuroblastoma, the most common and fatal form of...

2014-05-02 23:06:53

Minimally Invasive Procedure Showcases Future Treatment Options Pleasanton, CA (PRWEB) May 02, 2014 Sanarus Technologies welcomes the release of an abstract for the recently completed ACOSOG (Alliance) Z1072 Clinical Trial. The company’s proprietary Visica 2 Cryoablation Treatment System was used exclusively in the study, titled “A Phase II Trial Exploring the Success of Cryoablation in the Treatment of Invasive Breast Carcinoma”. The abstract states that “Cryoablation Shows...

2014-05-02 08:25:16

Large Study Published in The Oncologist Underscores Test's Value in Guiding Treatment Decisions REDWOOD CITY, Calif., May 2, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that The Oncologist published positive results from an Oncotype DX(®) colon cancer decision impact study, demonstrating that Recurrence Score(®) results changed treatment recommendations in 45 percent of stage II colon cancer patients. The study was conducted in collaboration with the...

2014-05-01 23:07:27

Cianna Medical: Early-stage breast cancer treatment enables more women to opt for partial breast radiation. Aliso Viejo, CA (PRWEB) May 01, 2014 Cianna Medical, Inc., a women’s health company, today announced the results of a trial examining the long-term side effects of strut-based brachytherapy for early-stage breast cancer. According to researchers, treatment with SAVI® breast brachytherapy resulted in very low rates of late toxicities, even in patients with minimal space...


Latest Breast cancer Reference Libraries

Clinical Breast Cancer
2012-06-04 20:06:33

Clinical Breast Cancer is a peer-reviewed medical journal established in 2000 and published bimonthly by Elsevier. As of May 2012, the editor-in-chief is George W. Sledge, Jr. The journal publishes original articles describing various aspects of clinical and translational research of breast cancer. It is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer....

Breast Cancer Research and Treatment
2012-05-07 07:48:55

Breast Cancer Research and Treatment is a peer-reviewed scientific journal published by Springer Verlag. It focuses on the treatment of and investigations in breast cancer. The journal is targeted towards a wide audience of clinical researchers, epidemiologists, immunologists, and cell biologists whom are interested in breast cancer. Articles in this journal include: original research, invited reviews, discussions on controversial issues, book reviews, meeting reports, letters to the editors,...

More Articles (2 articles) »
Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related